Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Aug;53(8):2620-2627.
doi: 10.1161/STROKEAHA.121.038239. Epub 2022 May 11.

Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study

Maurizio Paciaroni #  1   2 Valeria Caso #  2 Giancarlo Agnelli  2 Maria Giulia Mosconi  2 Michela Giustozzi  2 David Julian Seiffge  3   4 Stefan T Engelter  3 Philippe Lyrer  3 Alexandros A Polymeris  3 Lilian Kriemler  3 Annaelle Zietz  3 Jukka Putaala  5 Daniel Strbian  5 Liisa Tomppo  5 Patrik Michel  6 Davide Strambo  6 Alexander Salerno  6 Suzette Remillard  6 Manuela Buehrer  6 Odessa Bavaud  6 Peter Vanacker  7   8   9 Susanna Zuurbier  7   8 Laetitia Yperzeele  7   8 Caroline M J Loos  7   8 Manuel Cappellari  10 Andrea Emiliani  10 Marialuisa Zedde  11 Azmil Abdul-Rahim  12 Jesse Dawson  12 Robert Cronshaw  12 Erika Schirinzi  13 Massimo Del Sette  13 Christoph Stretz  14 Narendra Kala  14 Michael Reznik  14 Ashley Schomer  14 Brian Mac Grory  14   15 Mahesh Jayaraman  14 Ryan McTaggart  14 Shadi Yaghi  14 Karen L Furie  14 Luca Masotti  16 Elisa Grifoni  16 Danilo Toni  17 Angela Risitano  17 Anne Falcou  18 Luca Petraglia  17 Enrico Maria Lotti  19 Marina Padroni  19 Lucia Pavolucci  19 Piergiorgio Lochner  20 Giorgio Silvestrelli  21 Alfonso Ciccone  21 Andrea Alberti  2 Michele Venti  2 Laura Traballi  2 Chiara Urbini  2 Odysseas Kargiotis  22 Alessandro Rocco  23 Marina Diomedi  23 Simona Marcheselli  24 Pietro Caliandro  25 Aurelia Zauli  26 Giuseppe Reale  26 Kateryna Antonenko  27 Eugenia Rota  28 Tiziana Tassinari  29 Valentina Saia  29 Francesco Palmerini  30 Paolo Aridon  31 Valentina Arnao  32 Serena Monaco  32 Salvatore Cottone  32 Antonio Baldi  33 Cataldo D'Amore  33 Walter Ageno  34 Samuela Pegoraro  34 George Ntaios  35 Dimitrios Sagris  35 Sotirios Giannopoulos  36 Maria Kosmidou  36 Evangelos Ntais  36 Michele Romoli  37 Leonardo Pantoni  38 Silvia Rosa  39 Pierluigi Bertora  38 Alberto Chiti  40 Isabella Canavero  41   42 Carlo Emanuele Saggese  43 Maurizio Plocco  43 Elisa Giorli  44 Lina Palaiodimou  45 Eleni Bakola  45 Georgios Tsivgoulis  45 Fabio Bandini  46 Antonio Gasparro  47 Valeria Terruso  47 Marina Mannino  47 Alessandro Pezzini  48 Raffaele Ornello  49 Simona Sacco  49 Nemanja Popovic  50 Umberto Scoditti  51 Antonio Genovese  51 Licia Denti  52 Yuriy Flomin  53 Michelangelo Mancuso  54 Elena Ferrari  54 Maria Chiara Caselli  54 Leonardo Ulivi  54 Nicola Giannini  54 Gian Marco De Marchis  3
Affiliations
Free article
Observational Study

Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study

Maurizio Paciaroni et al. Stroke. 2022 Aug.
Free article

Abstract

Background: In patients with atrial fibrillation who suffered an ischemic stroke while on treatment with nonvitamin K antagonist oral anticoagulants, rates and determinants of recurrent ischemic events and major bleedings remain uncertain.

Methods: This prospective multicenter observational study aimed to estimate the rates of ischemic and bleeding events and their determinants in the follow-up of consecutive patients with atrial fibrillation who suffered an acute cerebrovascular ischemic event while on nonvitamin K antagonist oral anticoagulant treatment. Afterwards, we compared the estimated risks of ischemic and bleeding events between the patients in whom anticoagulant therapy was changed to those who continued the original treatment.

Results: After a mean follow-up time of 15.0±10.9 months, 192 out of 1240 patients (15.5%) had 207 ischemic or bleeding events corresponding to an annual rate of 13.4%. Among the events, 111 were ischemic strokes, 15 systemic embolisms, 24 intracranial bleedings, and 57 major extracranial bleedings. Predictive factors of recurrent ischemic events (strokes and systemic embolisms) included CHA2DS2-VASc score after the index event (odds ratio [OR], 1.2 [95% CI, 1.0-1.3] for each point increase; P=0.05) and hypertension (OR, 2.3 [95% CI, 1.0-5.1]; P=0.04). Predictive factors of bleeding events (intracranial and major extracranial bleedings) included age (OR, 1.1 [95% CI, 1.0-1.2] for each year increase; P=0.002), history of major bleeding (OR, 6.9 [95% CI, 3.4-14.2]; P=0.0001) and the concomitant administration of an antiplatelet agent (OR, 2.8 [95% CI, 1.4-5.5]; P=0.003). Rates of ischemic and bleeding events were no different in patients who changed or not changed the original nonvitamin K antagonist oral anticoagulants treatment (OR, 1.2 [95% CI, 0.8-1.7]).

Conclusions: Patients suffering a stroke despite being on nonvitamin K antagonist oral anticoagulant therapy are at high risk of recurrent ischemic stroke and bleeding. In these patients, further research is needed to improve secondary prevention by investigating the mechanisms of recurrent ischemic stroke and bleeding.

Keywords: anticoagulants; atrial fibrillation; hypertension; ischemic stroke; recurrence.

PubMed Disclaimer

References

Publication types

MeSH terms